Laurus Labs Ltd.

BSE: 540222 | NSE: LAURUSLABS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE947Q01028 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Laurus Labs Lt Laurus Labs Ltd. | BSE 1022.80 30.25 (3.05%) | NSE 1023.50 30.90 (3.11%) | Trade | Add

BSE Live

Mar 25, 16:01

1022.80 30.25 (3.05%)

Volume

AVERAGE VOLUME

5-Day

60,555

10-Day

65,809

30-Day

62,873

35,210

Prev. Close

992.55
Open Price

1004.40

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Mar 25, 15:59

1023.50 30.90 (3.11%)

Volume

AVERAGE VOLUME

5-Day

1,374,079

10-Day

1,763,920

30-Day

1,529,948

1,421,805

Prev. Close

992.60
Open Price

1009.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1023.50 (125)

Financials

Print/Copy to Excel : Go

Balance Sheet of Laurus Labs (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	107.85	107.79	107.73	107.47	107.32
Total Share Capital	107.85	107.79	107.73	107.47	107.32
Reserves and Surplus	4,456.10	4,099.26	3,949.09	3,280.74	2,604.92
Total Reserves and Surplus	4,456.10	4,099.26	3,949.09	3,280.74	2,604.92
Total Shareholders Funds	4,563.95	4,207.05	4,056.82	3,388.21	2,712.24
NON-CURRENT LIABILITIES
Long Term Borrowings	414.25	490.53	565.49	549.67	382.64
Deferred Tax Liabilities [Net]	35.63	66.31	76.74	70.23	26.87
Other Long Term Liabilities	314.16	79.54	74.05	96.53	91.71
Long Term Provisions	96.72	88.26	78.54	69.79	60.10
Total Non-Current Liabilities	860.76	724.64	794.82	786.22	561.32
CURRENT LIABILITIES
Short Term Borrowings	1,910.39	1,558.53	1,115.89	1,069.99	876.90
Trade Payables	928.70	996.78	666.36	849.23	1,158.54
Other Current Liabilities	295.32	156.48	304.65	499.10	303.92
Short Term Provisions	27.63	24.00	19.42	15.78	12.27
Total Current Liabilities	3,162.04	2,735.79	2,106.32	2,434.10	2,351.63
Total Capital And Liabilities	8,586.75	7,667.48	6,957.96	6,608.53	5,625.19
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2,869.87	3,018.76	2,871.52	2,175.68	1,809.16
Intangible Assets	17.63	17.55	12.64	10.55	8.88
Capital Work-In-Progress	336.24	155.51	357.06	755.03	324.17
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	3,223.74	3,191.82	3,241.22	2,941.26	2,142.21
Non-Current Investments	740.22	634.87	384.12	361.72	318.89
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	466.50	226.50	64.50	0.00	0.00
Other Non-Current Assets	149.51	97.18	96.86	100.98	122.64
Total Non-Current Assets	4,579.97	4,150.37	3,786.70	3,403.96	2,583.74
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	1,738.88	1,697.16	1,569.27	1,688.70	1,533.52
Trade Receivables	2,035.07	1,640.50	1,487.42	1,269.15	1,279.82
Cash And Cash Equivalents	50.64	42.92	1.70	40.56	38.78
Short Term Loans And Advances	6.69	6.60	6.59	88.75	44.85
OtherCurrentAssets	175.50	129.93	106.28	117.41	144.48
Total Current Assets	4,006.78	3,517.11	3,171.26	3,204.57	3,041.45
Total Assets	8,586.75	7,667.48	6,957.96	6,608.53	5,625.19
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1,093.33	887.54	677.17	475.95	629.35
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	0.00
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.00	0.00	0.00
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	1,318.00	1,215.00	1,372.00	1,317.00	1,656.00
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	--
Other Earnings	3,489.00	3,054.00	4,347.00	3,437.00	3,325.00
BONUS DETAILS
Bonus Equity Share Capital	73.97	73.97	73.97	73.97	73.97
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	740.22	3.41	3.41	3.41	3.41
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--